Investors Are Waking Up To Amneal Pharmaceuticals Inc (NASDAQ: AMRX) After Rising 15.26% Over The Past 12 Months

Amneal Pharmaceuticals Inc (NASDAQ:AMRX) currently has a daily average trading volume of 1.92M but it saw 1546855 shares traded in last market. With a market cap of 2.44B USD, the company’s current market price of $7.78 came falling about -0.38 while comparing to the previous closing price of $7.81. In past 52 weeks, the stock remained buoying in the range of price level as high as $9.48 and as low as $6.29.

The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Goldman which initiated the stock as “Buy” in its note to investors issued on June 06, 2025, recommending a price target of $12 for it. JP Morgan upgraded its recommendation for the stock as a “Overweight” from “Neutral” on February 24, 2025 while assigning a price target range of $9-$12. JP Morgan issued its recommendations for the stock as it upgraded the price target for the stock is $9.

Over the week, AMRX’s stock price is moving 7.91% up while it is 2.37% when we observe its performance for the past one month. Year-to-date it is -1.77% down and over the past year, the stock is showing an upside performance of 15.26%.

Currently, Amneal Pharmaceuticals Inc’s total number of outstanding shares is 313.38M. Company’s return on investment (ROI) stands at -0.62% and return on equity (ROE) at -155.38%. It has a 9.40 of forward P/E ratio. Stock’s beta reads 1.06. Stock has a price to sale or P/S ratio amounts to 0.86. Its return on asset (ROA) is -0.38% on average.

Comet Reports
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.